Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device
513(g) submission is a key milestone that marks the initiation of Median’s interactions with the FDA. 513(g) submission will allow Median Technologies to determine the...
